Taking into consideration that CYP24A1 degrades both calcidiol and calcitriol, its expression might be upregulated by cancer cells and lead to reduced local concentrations of 1,25(OH)2D3 reported by Albertson et al., who found amplified CYP24A1 in breast cancer [67]. The gene discussed is CYP24A1; the disease is breast carcinoma.